Yuly A. Remolina(@Yuly_Remo) 's Twitter Profileg
Yuly A. Remolina

@Yuly_Remo

Colombiana, oncóloga y feliz! // oncologist interested in GU and breast/gyn cancers

ID:346701774

calendar_today01-08-2011 18:09:45

431 Tweets

196 Followers

519 Following

Enrique Soto(@EnriqueSoto8) 's Twitter Profile Photo

Our manuscript on the priorities of older patients regarding outcomes in cancer care is out in ACS Journal Cancer.
Here , we studied which outcomes were more important for older adults starting chemo. City of Hope Conquer Cancer, the ASCO Foundation
FREE here ⬇️
doi.org/10.1002/cncr.3…

Our manuscript on the priorities of older patients regarding outcomes in cancer care is out in @JournalCancer. Here , we studied which outcomes were more important for older adults starting chemo. #gerionc @cityofhope @ConquerCancerFd FREE here ⬇️ doi.org/10.1002/cncr.3…
account_circle
Maite Bourlon(@BourlonMaite) 's Twitter Profile Photo

🗣️🌍👩🏻‍⚕️👨🏻‍⚕️ ASCO JCO Global Oncology published Competencies for Global Oncology Training

🔸Knowledge & Skills need in global health & cancer specific care
🔹 Understand disparities, define resources in LMICs & promote international collaboration

OncoAlert OncoDaily

🗣️🌍👩🏻‍⚕️👨🏻‍⚕️ @ASCO @JCOGO_ASCO published Competencies for Global Oncology Training 🔸Knowledge & Skills need in global health & cancer specific care 🔹 Understand disparities, define resources in LMICs & promote international collaboration #globaloncology @OncoAlert @oncodaily
account_circle
carolina jaramillo s(@carojarasanta) 's Twitter Profile Photo

Les traigo fotos de desayunos de las diferentes regiones de Colombia 🇨🇴
Caldo de costilla de res
Changua
Del altiplano cundiboyacense

Les traigo fotos de desayunos de las diferentes regiones de Colombia 🇨🇴 Caldo de costilla de res Changua Del altiplano cundiboyacense
account_circle
Paolo Tarantino(@PTarantinoMD) 's Twitter Profile Photo

T-DXd is approved for the treatment of patients with ANY treatment-refractory HER2+ (IHC 3+) tumor, making of it the first agnostic ADC. Unlikely to be the last. Key priority: ensuring that HER2 testing is expanded across cancer types. Exciting times! fda.gov/drugs/resource…

T-DXd is approved for the treatment of patients with ANY treatment-refractory HER2+ (IHC 3+) tumor, making of it the first agnostic ADC. Unlikely to be the last. Key priority: ensuring that HER2 testing is expanded across cancer types. Exciting times! fda.gov/drugs/resource…
account_circle
Sociedad Mexicana de Oncología, A.C.(@SMEOMX) 's Twitter Profile Photo

No te pierdas nuestra Sesión Académica (híbrida)

'Actualidades en el tratamiento de Cáncer de Cavidad Oral' el sábado 13 de abril de 2024, 09:00 hrs.

Registro y transmisión virtual shorturl.at/gnxO6

Presencial:
Hotel BelAir Unique. Salón México

No te pierdas nuestra Sesión Académica (híbrida) 'Actualidades en el tratamiento de Cáncer de Cavidad Oral' el sábado 13 de abril de 2024, 09:00 hrs. Registro y transmisión virtual shorturl.at/gnxO6 Presencial: Hotel BelAir Unique. Salón México #todosomosmeo #Cancer
account_circle
Yüksel Ürün(@DrYukselUrun) 's Twitter Profile Photo

Today marks a historic day for urothelial cancers.
The full text of EV-302 has been published in NEJM coinciding with the FDA’s approval of CM-901. While the impressive efficacy of EV-P is undeniable, accessibility remains a significant barrier.
As scientists, our objective is…

Today marks a historic day for urothelial cancers. The full text of EV-302 has been published in @NEJM coinciding with the FDA’s approval of CM-901. While the impressive efficacy of EV-P is undeniable, accessibility remains a significant barrier. As scientists, our objective is…
account_circle
David Gandara(@drgandara) 's Twitter Profile Photo

Sorry to see this news. “Giant killer” Docetaxel dispatches another opponent. This time a targeted therapy ADC in a biomarker enriched population

account_circle
Yuly A. Remolina(@Yuly_Remo) 's Twitter Profile Photo

Impact of healthcare inequities on survival in Mexican patients with metastatic renal cell carcinoma frontiersin.org/articles/10.33…

account_circle
Dr. Saadvik Raghuram y(@saadvikdr) 's Twitter Profile Photo

🚨 Another immunotherapy success in cervical cancer

🔹metastatic/relapsed cervical cancer & treatment naive

🔹 SOC pacli/carbo/bev VS atezo/bev/pacli/carbo

🔹 mPFS 8.5 vs 12.7mo (HR 0.62)

🔹 mOS 22.8 vs 31mo (HR 0.68)

It’s wonderful to see more and more options in cervical…

🚨 Another immunotherapy success in cervical cancer 🔹metastatic/relapsed cervical cancer & treatment naive 🔹 SOC pacli/carbo/bev VS atezo/bev/pacli/carbo 🔹 mPFS 8.5 vs 12.7mo (HR 0.62) 🔹 mOS 22.8 vs 31mo (HR 0.68) It’s wonderful to see more and more options in cervical…
account_circle
Johnathan Ebben MD, PhD(@JohnEbbenMDPhD) 's Twitter Profile Photo

Eosinophils play a confusing role in cancer development. MarleenKokLab shows today at that in eosinophils are a biomarker of IO activity.

— Eosinophils boost CD8 TIL activity

How does context change pro vs anti-tumor effects of eos? Can peripheral eo counts be a…

Eosinophils play a confusing role in cancer development. @lab_kok shows today at #sitc23 that in #tnbc eosinophils are a biomarker of IO activity. — Eosinophils boost CD8 TIL activity How does context change pro vs anti-tumor effects of eos? Can peripheral eo counts be a…
account_circle
Ramiro Esparza(@docramiro) 's Twitter Profile Photo

Los gatos domésticos tienen 276 diferentes expresiones faciales para comunicarse:
- 45% amigables
- 37% agresivas
- Resto ambiguas
¿Logras identificarlas en tu 🐱?
Referencia DOI: 10.1016/j.beproc.2023.104959

Los gatos domésticos tienen 276 diferentes expresiones faciales para comunicarse: - 45% amigables - 37% agresivas - Resto ambiguas ¿Logras identificarlas en tu 🐱? Referencia DOI: 10.1016/j.beproc.2023.104959
account_circle
Matt Galsky(@MattGalsky) 's Twitter Profile Photo

There is really important biology hiding in plain sight in IMvigor130, KN361, CM901, and EV302. This provides some direction on how to move forward. Lets celebrate the wins & think carefully about the future. Uromigos Michiel van der Heijden Tom Powles Jonathan Rosenberg MD Petros Grivas

account_circle